BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 34144253)

  • 1. Blood transfusion and venous thromboembolism trends and risk factors in primary and aseptic revision total hip and knee arthroplasties: A nationwide investigation of 736,061 cases.
    Jeschke E; Citak M; Halder AM; Heller KD; Niethard FU; Schräder P; Zacher J; Leicht H; Malzahn J; Günster C; Gehrke T
    Orthop Traumatol Surg Res; 2022 Feb; 108(1):102987. PubMed ID: 34144253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tranexamic Acid Was Safe in Arthroplasty Patients With a History of Venous Thromboembolism: A Matched Outcome Study.
    Sabbag OD; Abdel MP; Amundson AW; Larson DR; Pagnano MW
    J Arthroplasty; 2017 Sep; 32(9S):S246-S250. PubMed ID: 28262452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Venous thromboembolism and mortality associated with tranexamic acid use during total hip and knee arthroplasty.
    Duncan CM; Gillette BP; Jacob AK; Sierra RJ; Sanchez-Sotelo J; Smith HM
    J Arthroplasty; 2015 Feb; 30(2):272-6. PubMed ID: 25257237
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative Epidemiology of Revision Arthroplasty: Failed THA Poses Greater Clinical and Economic Burdens Than Failed TKA.
    Bozic KJ; Kamath AF; Ong K; Lau E; Kurtz S; Chan V; Vail TP; Rubash H; Berry DJ
    Clin Orthop Relat Res; 2015 Jun; 473(6):2131-8. PubMed ID: 25467789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tranexamic Acid Is Safe in Patients with a History of Venous Thromboembolism Undergoing Total Joint Arthroplasty.
    Richardson MK; Liu KC; Mayfield CK; Kistler NM; Lieberman JR; Heckmann ND
    J Bone Joint Surg Am; 2024 Jan; 106(1):30-38. PubMed ID: 37967163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
    Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
    J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Risk of Venous Thromboembolism in Patients with Postoperative Anemia After Total Joint Arthroplasty: Are Transfusions to Blame?
    Liu KC; Piple AS; Richardson MK; Mayer LW; Mayfield CK; Christ AB; Lieberman JR; Heckmann ND
    J Bone Joint Surg Am; 2023 Sep; 105(17):1354-1361. PubMed ID: 37471565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous tranexamic acid safely and effectively reduces transfusion rates in revision total hip arthroplasty.
    Hines JT; Hernandez NM; Amundson AW; Pagnano MW; Sierra RJ; Abdel MP
    Bone Joint J; 2019 Jun; 101-B(6_Supple_B):104-109. PubMed ID: 31146563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous Tranexamic Acid Safely and Effectively Reduces Transfusion Rates in Revision Total Knee Arthroplasties.
    Hines JT; Petis SM; Amundson AW; Pagnano MW; Sierra RJ; Abdel MP
    J Bone Joint Surg Am; 2020 Mar; 102(5):381-387. PubMed ID: 31977819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk calculators predict failures of knee and hip arthroplasties: findings from a large health maintenance organization.
    Paxton EW; Inacio MC; Khatod M; Yue E; Funahashi T; Barber T
    Clin Orthop Relat Res; 2015 Dec; 473(12):3965-73. PubMed ID: 26324831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does Hemophilia Increase Risk of Adverse Outcomes Following Total Hip and Knee Arthroplasty? A Propensity Score-Matched Analysis of a Nationwide, Population-Based Study.
    Wang SH; Chung CH; Chen YC; Cooper AM; Chien WC; Pan RY
    J Arthroplasty; 2019 Oct; 34(10):2329-2336.e1. PubMed ID: 31337553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors associated with hospital stay length, discharge destination, and 30-day readmission rate after primary hip or knee arthroplasty: Retrospective Cohort Study.
    Roger C; Debuyzer E; Dehl M; Bulaïd Y; Lamrani A; Havet E; Mertl P
    Orthop Traumatol Surg Res; 2019 Sep; 105(5):949-955. PubMed ID: 31208932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spondyloarthritis is associated with higher healthcare utilization and complication rates after primary total knee or total hip arthroplasty.
    Singh JA; Cleveland JD
    Clin Rheumatol; 2020 Aug; 39(8):2345-2353. PubMed ID: 32172464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Trends in Blood Utilization After Revision Hip and Knee Arthroplasty.
    Burnett RA; Bedard NA; DeMik DE; Gao Y; Liu SS; Callaghan JJ
    J Arthroplasty; 2017 Dec; 32(12):3693-3697. PubMed ID: 28951054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological thromboprophylaxis and its impact on venous thromboembolism following total knee and hip arthroplasty in Korea: A nationwide population-based study.
    Yhim HY; Lee J; Lee JY; Lee JO; Bang SM
    PLoS One; 2017; 12(5):e0178214. PubMed ID: 28542415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
    Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
    J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sjogren's syndrome is associated with higher rate of non-home discharge after primary hip arthroplasty and higher transfusion rates after primary hip or knee arthroplasty: a U.S. cohort study.
    Singh JA; Cleveland JD
    BMC Musculoskelet Disord; 2020 Jul; 21(1):492. PubMed ID: 32711507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Who Is Still Receiving Blood Transfusions After Primary and Revision Total Joint Arthroplasty?
    DeMik DE; Carender CN; Glass NA; Brown TS; Callaghan JJ; Bedard NA
    J Arthroplasty; 2022 Jun; 37(6S):S63-S69.e1. PubMed ID: 34511282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bleeding and thromboembolism risk of standard antithrombotic prophylaxis after hip or knee replacement within an enhanced recovery program.
    Jenny JY; Bulaid Y; Boisrenoult P; Bonin N; Henky P; Tracol P; Chouteau J; Courtin C; Henry MP; Schwartz C; Mertl P; De Ladoucette A;
    Orthop Traumatol Surg Res; 2020 Dec; 106(8):1533-1538. PubMed ID: 33127330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topical tranexamic acid reduces blood loss and transfusion rates associated with primary total hip arthroplasty.
    Chang CH; Chang Y; Chen DW; Ueng SW; Lee MS
    Clin Orthop Relat Res; 2014 May; 472(5):1552-7. PubMed ID: 24385043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.